A review of the device history records was performed for the reported packaging lot for any deviations related to the reported defect of the complaint.The review confirms that the lot met all material, assembly and performance specifications.The angiodynamics recent complaint report was reviewed for the stopcock/manifold product family and the failure mode,"package hole/perforated." no adverse trends were identified.The returned sample was visually inspected and the hole in the tyvek portion of the 4 x 8 pouch was confirmed.The damage appears to have been the result of the blue stopcock handle causing the hole.The pouch appeared to have been "severely handled." as part of the receiving process at nipro (the distributor in (b)(6)), all pouched products are removed from their inner boxes and a nipro label (in (b)(6)) is applied to each pouch.Additional handling may occur if product is 100% visually inspected.The pouched product is then reboxed into the inner box by the nipro warehouse employees.The exact root cause of the device pressing against the tyvek in a manner that resulted in a hole cannot be determined.Potential contributing factors include: - handling during transit to nipro warehouse.- handling during nipro labeling/inspection and re-boxing process.All pouches are 100% inspected per angiodynamics procedures during the sealing and final box processes.This is an obvious defect that would have been detected.The directions for use (dfu) packaged with the kits contain the following warning: "contents supplied sterile using an ethylene oxide (eo) process.Do not use if sterile barrier is damaged." (b)(4).
|
As reported by angiodynamics' distributor in (b)(6), in the distributor's warehouse a hole/tear was found in the tyvek portion of a stopcock pouch, breaching the sterility.The product had not been provided to a hospital and was returned to angiodynamics for evaluation.
|